Once per cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma.

被引：0

作者：

Wendelin, G ^{[1
]}

Lackner, H ^{[1
]}

Schwinger, W ^{[1
]}

Sovinz, P ^{[1
]}

Urban, C ^{[1
]}

机构：

[1] Med Univ Graz, Dept Pediat Hematol & Oncol, Graz, Austria

来源：

BLOOD | 2004年 / 104卷 / 11期

关键词：

D O I：

10.1182/blood.V104.11.2919.2919

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2919

引用

页码：798A / 798A

页数：1

共 50 条

[31] Pegfilgrastim Administered Once Per Cycle Reduces Incidence of Chemotherapy-Induced Neutropenia
Jeffrey Crawford
Drugs, 2002, 62 : 89 - 98
[32] Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study
Rossi, Luigi
Tomao, Federica
Lo Russo, Giuseppe
Papa, Anselmo
Zoratto, Federica
Marzano, Raffaella
Basso, Enrico
Giordani, Erika
Verrico, Monica
Ricci, Fabio
Pasciuti, Giulia
Francini, Edoardo
Tomao, Silverio
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 457 - 462
[33] ASSESSMENT COST-EFFECTIVENESS OF PEGFILGRASTIM AND FILGRASTIM IN PEDIATRIC PATIENTS WITH SOLID TUMORS
Medina Barajas, F. P.
Sanchez Zubieta, F.
Islas Carbajal, M. C.
Pardo Zepeda, M.
Ramirez Urenda, X.
Rincon Sanchez, A. R.
VALUE IN HEALTH, 2014, 17 (03) : A87 - A87
[34] Value of local treatment modalities in patients with localized Ewing Sarcoma. Report from the Ewing 2008 trial
Heesen, Philip
Ranft, Andreas
Bhadri, Vivek
Brichard, Benedicte
Collaud, Stephane
Cyprova, Sona
Eich, Hans
Ek, Torben
Gelderblom, Hans
Hardes, Jendrik
Haveman, Lianne
Hartmann, Wolfgang
Hauser, Peter
Jurgens, Heribert
Kanerva, Jukka
Kuehne, Thomas
Raciborska, Anna
Rascon, Jelena
Streitbuerger, Arne
Timmermann, Beate
Uhlenbruch, Yasmine
Dirksen, Uta
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 233 - 233
[35] Disparate Outcomes, Biologic and Therapeutic Differences in Pediatric versus Adult Patients with Ewing Sarcoma
Wytiaz, Victoria
Schwartz, Eric
Rice, John D.
Zhao, Lili
Jasty, Rama
Schuetze, Scott
Chugh, Rashmi
ONCOLOGY, 2024, 102 (01) : 1 - 8
[36] Neulasta (Pegfilgrastim): A once-per-cycle option for the management of chemotherapy-induced neutropenia
Biganzoli, L
Untch, M
Skacel, T
Pico, JL
SEMINARS IN ONCOLOGY, 2004, 31 (03) : 27 - 34
[37] Lipegfilgrastim: A long-acting, once-per-cycle, glycopegylated recombinant human filgrastim
Scheckermann, Christian
Schmidt, Karsten
Abdolzade-Bavil, Afsaneh
Allgaier, Hermann
Mueller, Udo W.
Shen, Wenyan David
Liu, Patrick
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[38] Once per cycle combination of long-acting hematopoietic growth factors (HGFs) pegfilgrastim and darbepoetin alfa (Peg-G plus DPO) to reduce multi-lineage hematopoietic toxicity of chemotherapy with doxorubicin and ifosfamide (AI), in patients with sarcoma.
Vadhan-Raj, S
Trent, J
Burgess, MA
Patel, S
Collard, ML
Zachariah, G
Hangoc, G
Johnson, M
Broxmeyer, HE
Benjamin, RS
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 784S - 784S
[39] I VALUE OF LOCAL TREATMENT MODALITIES IN PATIENTS WITH LOCALIZED EWING SARCOMA. REPORT FROM THE EWING 2008 TRIAL
Heesen, Philip
Ranft, Andreas
Bhadri, Vivek
Brichard, Benedicte
Collaud, Stephane
Cyprova, Sona
Eich, Hans
Ek, Torben
Gelderblom, Hans
Hardes, Jendrik
Haveman, Lianne
Hartmann, Wolfgang
Hauser, Peter
Jurgens, Heribert
Kanerva, Jukka
Kuehne, Thomas
Raciborska, Anna
Rascon, Jelena
Streitbuerger, Arne
Timmermann, Beate
Uhlenbruch, Yasmine
Dirksen, Uta
PEDIATRIC BLOOD & CANCER, 2022, 69
[40] EWING SARCOMA IN PEDIATRIC PATIENTS: A REPORT OF INSTITUTIONAL RESULTS
Fernandes, Flavia
Couto, Cristiana
Conde, Sofia
Pires, Andreia
Aguiar, Artur
Sousa, Catarina
Sousa, Catia
Silva, Silvia
Ferreira, Ana
PEDIATRIC BLOOD & CANCER, 2022, 69 : S601 - S601

← 1 2 3 4 5 →